Episode 6: The Unknown Unknowns

Episode 6: The Unknown Unknowns — How Much Intel Are Your Competitors Gathering?

Episode 6 pulls back the curtain on competitive intelligence (CI) maturity in severe asthma launches—what top teams track, how fast they learn, and why it matters for pricing, access, messaging, and patient support. We contrast integrated, always-on CI programs with reactive, vendor-only approaches, and show how social listening, field feedback loops, KOL digital patterns, and payer advisory monitoring translate into real decisions. You’ll also hear the most common failure points—time lag from signal to action, siloed insights, and low field trust—and how Lumara can build an “always-on” CI operating system before launch.

What you’ll learn

• The CI modalities that actually change strategy (field synthesis, payer boards, social signal mining, KOL patterns)

• How dominant vs. challenger brands structure CI—and where they stumble

• Practical ways to close gaps: dashboards, incentives, Medical/Access triangulation, faster synthesis-to-action cycles

• How to estimate what rivals already know about you—and plan accordingly

Featured segments

• Inside the CI Stack: From Field Notes to Signals that Stick

• Benchmarks & Blind Spots: What the Best Teams Do Differently

• Build the OS: Always-On CI, Incentives, and Weekly Cadence